Denosumab Prescribing at ROTHSCHILD HOUSE GROUP
Drugs affecting bone metabolism | Endocrine System
Items (12m)
236
Total Quantity
237
NHS Cost
£38.8K
vs National Avg
+767.2%
ROTHSCHILD HOUSE GROUP prescribed 236 items of Denosumab over the last 12 months at a cost of £38,756 to the NHS. This is 767.2% above the national average prescribing rate. Denosumab is classified under Drugs affecting bone metabolism in the BNF.
Monthly Prescribing Trend
Jun 2026
14
Jun 2026
23
Jun 2026
5
Jun 2026
35
Jun 2026
24
Jun 2026
9
Jun 2026
33
Jun 2026
14
Jun 2026
15
Jun 2026
22
Jun 2026
24
Jun 2026
18
Prescribing Details
| Total Items | 236 |
|---|---|
| Total Quantity | 237 |
| Total NHS Cost | £38,756 |
| Presentations | 2 different forms |
| vs National Average | +767.2% |
Denosumab Prescribing Comparison
| This practice | 236 items |
|---|---|
| National average per practice | 27 items |
| Difference | +767.2% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.